Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Circulating Nucleic Acids and Circulating Rare Cells: Liquid Biopsy for Early Cancer Detection

Allison Welsh's Biography



Allison Welsh, Associate Director, Liquid Biopsy Development, Foundation Medicine

Alley is Associate Director, Liquid Biopsy Development at Foundation Medicine (Cambridge MA), where she has been focused on clinical research and development of liquid biopsies. She joined Foundation Medicine in 2013, initially to lead CTC research efforts, and has since broadened to working on multiple levels to improve the utility of liquid biopsies in the clinical setting, and to advance education around the unique challenges they pose. She developed her initial experience in CTC biology and NGS-based approaches while working as a Postdoc Fellow studying single-cell genomics in metastatic prostate and breast cancer at Memorial Sloan-Kettering Cancer Center and Cold Spring Harbor Laboratory between 2011-2013. Alley has had a longstanding interest in the development and validation of clinical assays, and originally obtained her Ph.D. in Pathology from Yale University, studying the role of Estrogen Receptor (ER) in breast cancer.

Allison Welsh Image

Challenges and Opportunities For Liquid Biopsies (ctDNA) in the Clinical Setting

Thursday, 29 March 2018 at 10:00

Add to Calendar ▼2018-03-29 10:00:002018-03-29 11:00:00Europe/LondonChallenges and Opportunities For Liquid Biopsies (ctDNA) in the Clinical SettingSELECTBIOenquiries@selectbiosciences.com


Add to Calendar ▼2018-03-28 00:00:002018-03-29 00:00:00Europe/LondonCirculating Nucleic Acids and Circulating Rare Cells: Liquid Biopsy for Early Cancer Detection SELECTBIOenquiries@selectbiosciences.com